Your browser doesn't support javascript.
loading
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
Saeed, Anwaar; Park, Robin; Dai, Junqiang; Al-Rajabi, Raed; Kasi, Anup; Baranda, Joaquina; Williamson, Stephen; Saeed, Azhar; Ripp, Jacob; Collins, Zachary; Mulvaney, Kelly; Shugrue, Molly; Firth-Braun, Jeanette; Godwin, Andrew K; Madan, Rashna; Phadnis, Milind; Sun, Weijing.
Afiliação
  • Saeed A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsbur
  • Park R; Division of Hematology and Medical Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Dai J; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Al-Rajabi R; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Kasi A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Baranda J; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Williamson S; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Saeed A; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
  • Ripp J; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Collins Z; Department of Radiology, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Mulvaney K; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Shugrue M; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Firth-Braun J; Kansas University Cancer Center, Kansas City, KS 66205, USA.
  • Godwin AK; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Madan R; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Phadnis M; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA.
  • Sun W; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
Cell Rep Med ; 4(2): 100916, 2023 02 21.
Article em En | MEDLINE | ID: mdl-36702123
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article